113 related articles for article (PubMed ID: 11182565)
1. Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker.
Gudjonssona O; Bergström M; Kristjansson S; Wu F; Nyberg G; Fasth KJ; Långström B
Nucl Med Biol; 2001 Jan; 28(1):59-65. PubMed ID: 11182565
[TBL] [Abstract][Full Text] [Related]
2. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
[TBL] [Abstract][Full Text] [Related]
3. Elimination of nonspecific radioactivity from [76Br]bromide in PET study with [76Br]bromodeoxyuridine.
Lu L; Bergström M; Fasth KJ; Wu F; Eriksson B; Långström B
Nucl Med Biol; 1999 Oct; 26(7):795-802. PubMed ID: 10628559
[TBL] [Abstract][Full Text] [Related]
4. [76Br]Bromodeoxyuridine PET in tumor-bearing animals.
Gardelle O; Roelcke U; Vontobel P; Crompton NE; Guenther I; Bläuenstein P; Schubiger AP; Blattmann H; Ryser JE; Leenders KL; Kaser-Hotz B
Nucl Med Biol; 2001 Jan; 28(1):51-7. PubMed ID: 11182564
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of [76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats.
Lu L; Bergström M; Fasth KJ; Langström B
J Nucl Med; 2000 Oct; 41(10):1746-52. PubMed ID: 11038007
[TBL] [Abstract][Full Text] [Related]
6. Measurement of the extracellular space in brain tumors using 76Br-bromide and PET.
Bruehlmeier M; Roelcke U; Bläuenstein P; Missimer J; Schubiger PA; Locher JT; Pellikka R; Ametamey SM
J Nucl Med; 2003 Aug; 44(8):1210-8. PubMed ID: 12902409
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.
Böni R; Bläuenstein P; Dummer R; von Schulthess GK; Schubiger PA; Steinert HC
Melanoma Res; 1999 Dec; 9(6):569-73. PubMed ID: 10661767
[TBL] [Abstract][Full Text] [Related]
8. [76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice.
Ryser JE; Bläuenstein P; Rémy N; Weinreich R; Hasler PH; Novak-Hofer I; Schubiger PA
Nucl Med Biol; 1999 Aug; 26(6):673-9. PubMed ID: 10587106
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate.
Roelcke U; Leenders KL; von Ammon K; Radü EW; Vontobel P; Günther I; Psylla M
J Neurooncol; 1996 Aug; 29(2):157-65. PubMed ID: 8858521
[TBL] [Abstract][Full Text] [Related]
10. Preferential accumulation of 11C in human brain tumors after intravenous injection of 11C-1-pyruvate.
Tsukiyama T; Hara T; Iio M; Kido G; Tsubokawa T
Eur J Nucl Med; 1986; 12(5-6):244-8. PubMed ID: 3023098
[TBL] [Abstract][Full Text] [Related]
11. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors.
Ak I; Gulbas Z; Altinel F; Vardareli E
Clin Nucl Med; 2003 Jan; 28(1):29-33. PubMed ID: 12493957
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.
Dupont S; Semah F; Loc'h C; Strijckmans V; Baulac M; Samson Y; Mazière B
J Nucl Med; 1999 Jun; 40(6):935-41. PubMed ID: 10452308
[TBL] [Abstract][Full Text] [Related]
16. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
18. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
19. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
20. Unusual uptake and retention of I-123 IMP in brain tumors.
Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
Clin Nucl Med; 1988 Oct; 13(10):742-7. PubMed ID: 3263244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
